A validated assay for measuring doxorubicin in biological fluids and tissues in an isolated lung perfusion model: matrix effect and heparin interference strongly influence doxorubicin measurements-Reference-Cited by-同舟云学术

A validated assay for measuring doxorubicin in biological fluids and tissues in an isolated lung perfusion model: matrix effect and heparin interference strongly influence doxorubicin measurements

Published:2003-10 Issue:3 Volume:33 Page:475-494
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Kümmerle A,Krueger T,Dusmet M,Vallet C,Pan Y,Ris H.B,Decosterd Laurent A

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference42 articles.

1. Adriamycin, 14-hydroxydaimomycin, a new antitumor antibiotic fromS. Peucetius var.caesius

2. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin

3. Pharmacokinetic-Pharmacodynamic Relationships of the Anthracycline Anticancer Drugs

4. Anthrazykline in der Krebstherapie

5. Etiologic Factors in Soft Tissue Sarcomas

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Study of Various Procedures for Extracting Doxorubicin from Animal Tissue Samples;Separations;2022-12-22

2. Application of Optical Methods for Determination of Concentration of Doxorubicin in Blood and Plasma;Pharmaceuticals;2022-01-18

3. Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusion;Journal of Pharmaceutical Analysis;2021-02

4. A review on various analytical methods for determination of anthracyclines and their metabolites as anti–cancer chemotherapy drugs in different matrices over the last four decades;TrAC Trends in Analytical Chemistry;2020-09

5. Osteosarcoma with lung metastases;Pediatric Hematology/Oncology and Immunopathology;2019-12-31